Immunotherapy-reversed compulsive, monoaminergic, circadian rhythm disorder in Morvan syndrome.
Spinazzi
M
M
Department of Neurosciences, University of Padova, Italy. marco.spinazzi@unipd.it
Argentiero
V
V
Zuliani
L
L
Palmieri
A
A
Tavolato
B
B
Vincent
A
A
D001379:Azathioprine / Q000627:therapeutic use; D001479:Basal Ganglia / Q000187:drug effects / Q000276:immunology / Q000503:physiopathology; D001480:Basal Ganglia Diseases / Q000150:complications / Q000276:immunology / Q000503:physiopathology; D015306:Biogenic Monoamines / Q000378:metabolism*; D002395:Catecholamines / Q000378:metabolism; D021081:Chronobiology Disorders / Q000188:drug therapy* / Q000276:immunology / Q000503:physiopathology; D003192:Compulsive Behavior / Q000188:drug therapy* / Q000276:immunology; D003520:Cyclophosphamide / Q000627:therapeutic use; D004700:Endocrine System Diseases / Q000188:drug therapy / Q000276:immunology / Q000503:physiopathology; D004827:Epilepsy / Q000188:drug therapy / Q000276:immunology / Q000503:physiopathology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007167:Immunotherapy / Q000379:methods*; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D020385:Myokymia / Q000150:complications* / Q000276:immunology / Q000503:physiopathology; D010956:Plasmapheresis; D049268:Positron-Emission Tomography; D024642:Potassium Channels, Voltage-Gated / Q000235:genetics / Q000276:immunology; D012701:Serotonin / Q000378:metabolism; D016896:Treatment Outcome
D015306:Biogenic Monoamines; D002395:Catecholamines; D007166:Immunosuppressive Agents; D024642:Potassium Channels, Voltage-Gated; D012701:Serotonin; D003520:Cyclophosphamide; D001379:Azathioprine